Guo‐Chun Zhou

1.1k total citations
46 papers, 655 citations indexed

About

Guo‐Chun Zhou is a scholar working on Complementary and alternative medicine, Molecular Biology and Oncology. According to data from OpenAlex, Guo‐Chun Zhou has authored 46 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Complementary and alternative medicine, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Guo‐Chun Zhou's work include Andrographolide Research and Applications (21 papers), Mosquito-borne diseases and control (10 papers) and Natural Compounds in Disease Treatment (5 papers). Guo‐Chun Zhou is often cited by papers focused on Andrographolide Research and Applications (21 papers), Mosquito-borne diseases and control (10 papers) and Natural Compounds in Disease Treatment (5 papers). Guo‐Chun Zhou collaborates with scholars based in China, Macao and United States. Guo‐Chun Zhou's co-authors include Decai Wang, Feng Li, Shaopeng Chen, Hao Cheng, Jingjing Li, Simon Ming‐Yuen Lee, Xia Sun, Huimin Cheng, Ying Wang and Yitao Wang and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Guo‐Chun Zhou

45 papers receiving 649 citations

Peers

Countries citing papers authored by Guo‐Chun Zhou

Since Specialization

Citations

This map shows the geographic impact of Guo‐Chun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Chun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Chun Zhou more than expected).

Fields of papers citing papers by Guo‐Chun Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo‐Chun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Chun Zhou. The network helps show where Guo‐Chun Zhou may publish in the future.

Co-authorship network of co-authors of Guo‐Chun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Guo‐Chun Zhou. A scholar is included among the top collaborators of Guo‐Chun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo‐Chun Zhou. Guo‐Chun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and synthesis of lactam analogs of andrographolide and discovery of their anticancer activity as dual EGFR and VEGFR2 inhibitors 2025 ·European Journal of Medicinal Chemistry ·Ran Chen, Lele Zhang, (unknown), Yanfen Cheng, Guicheng Zhang, (unknown), Xiao Jin, Gph Leung, Jingjing Li, Guo‐Chun Zhou	0
2	Exploration of novel hexahydropyrrolo[1,2-e]imidazol-1-one derivatives as antiviral agents against ZIKV and USUV 2023 ·European Journal of Medicinal Chemistry ·(unknown), Rachele Francese, Na Wang, Feng Li, Xia Sun, Bin Xu, Jinsong Liu, (unknown), Manuela Donalisio, David Lembo, Guo‐Chun Zhou	5
3	Discovery of Novel Andrographolide Derivatives as Antiviral Inhibitors against Human Enterovirus A71 2022 ·Pharmaceuticals ·(unknown), (unknown), Regina Ching Hua Lee, Feng Li, (unknown), Guo‐Chun Zhou, Justin Jang Hann Chu	12
4	Discovery of dehydroandrographolide derivatives with C19 hindered ether as potent anti-ZIKV agents with inhibitory activities to MTase of ZIKV NS5 2022 ·European Journal of Medicinal Chemistry ·(unknown), Guangfeng Zhou, Xintong Ge, (unknown), Chang‐Bo Zheng, Liu‐Meng Yang, (unknown), Chunyan Li, Sidong Xiong, Yong‐Tang Zheng, Guo‐Chun Zhou	10
5	Discovery of 14S-(2’-chloro-4’-nitrophenoxy)-8R/S,17-epoxy andrographolide as EV-A71 infection inhibitor 2021 ·Biochemical Pharmacology ·(unknown), (unknown), (unknown), Regina Ching Hua Lee, Justin Jang Hann Chu, Guo‐Chun Zhou	6
6	Synthesis and Characterization of Andrographolide Derivatives as Regulators of βAPP Processing in Human Cells 2021 ·Molecules ·(unknown), (unknown), Feng Li, (unknown), Jean‐François Hernandez, Guo‐Chun Zhou, Bruno Vincent	4
7	The new andrographolide derivative AGS-30 induces apoptosis in human colon cancer cells by activating a ROS-dependent JNK signalling pathway 2021 ·Phytomedicine ·(unknown), Xiaoping Wu, (unknown), Renkai Li, Jinming Zhang, (unknown), Simon Ming‐Yuen Lee, Gph Leung, Guo‐Chun Zhou, Jingjing Li	22
8	Andrographolide and Its 14-Aryloxy Analogues Inhibit Zika and Dengue Virus Infection 2020 ·Molecules ·Feng Li, (unknown), Xia Sun, Atchara Paemanee, Sittiruk Roytrakul, Decai Wang, Duncan R. Smith, Guo‐Chun Zhou	21
9	Inhibition of zika virus infection by fused tricyclic derivatives of 1,2,4,5-tetrahydroimidazo[1,5-a]quinolin-3(3aH)-one 2020 ·Bioorganic Chemistry ·Bin Xu, Emily M. Lee, Angélica Medina, Xia Sun, Decai Wang, Hengli Tang, Guo‐Chun Zhou	11
10	Design, synthesis and discovery of andrographolide derivatives against Zika virus infection 2019 ·European Journal of Medicinal Chemistry ·Feng Li, Emily M. Lee, Xia Sun, Decai Wang, Hengli Tang, Guo‐Chun Zhou	32
11	Andrographolide derivative ameliorates dextran sulfate sodium-induced experimental colitis in mice 2019 ·Biochemical Pharmacology ·Baojian Guo, (unknown), (unknown), Feng Li, Mei Jing, Lipeng Xu, Yuqiang Wang, Zaijun Zhang, (unknown), (unknown), Decai Wang, Guo‐Chun Zhou, Ying Wang	19
12	Discovery and preliminary SAR of 14-aryloxy-andrographolide derivatives as antibacterial agents with immunosuppressant activity 2018 ·RSC Advances ·Feng Li, (unknown), (unknown), Shaoru Chen, (unknown), (unknown), Decai Wang, Qi Zhao, Yitao Wang, Ying Wang, Guo‐Chun Zhou	19
13	Andrographolide derivative as STAT3 inhibitor that protects acute liver damage in mice 2018 ·Bioorganic & Medicinal Chemistry ·Shaoru Chen, Li Feng, (unknown), Decai Wang, Qi Zhao, Yitao Wang, Guo‐Chun Zhou, Ying Wang	17
14	Attenuation of Innate Immunity by Andrographolide Derivatives Through NF-κB Signaling Pathway 2017 ·Scientific Reports ·(unknown), Shaoru Chen, Kun Wang, (unknown), Yitao Wang, Decai Wang, Ying Wang, Guo‐Chun Zhou	35
15	An andrographolide derivative AGP-26b exhibiting anti-angiogenic activity in HUVECs and zebrafish via blocking the VEGFA/VEGFR2 signaling pathway 2017 ·Molecular BioSystems ·Bin Huang, (unknown), Jingjing Li, Shang Li, (unknown), Decai Wang, Binrui Yang, Judy Yuet‐Wa Chan, Huidong Yu, Gph Leung, Maggie Pui Man Hoi, Guo‐Chun Zhou, Simon Ming‐Yuen Lee	7
16	Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors 2016 ·European Journal of Medicinal Chemistry ·(unknown), Xiao‐Xia Shao, Dominik Graf, Chunguang Wang, Christian D. Klein, Jing Wang, Guo‐Chun Zhou	41
17	Discovery and SAR studies of methionine–proline anilides as dengue virus NS2B-NS3 protease inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Guo‐Chun Zhou, (unknown), Xiao‐Xia Shao, Fang Liu, (unknown), Jinsong Liu, Decai Wang, Chunguang Wang, Kai Guo	26
18	Design, synthesis and evaluation of a cellular stable and detectable biotinylated fumagillin probe and investigation of cell permeability of fumagillin and its analogs to endothelial and cancer cells 2013 ·European Journal of Medicinal Chemistry ·Guo‐Chun Zhou, Fang Liu, Junting Wan, Jing Wang, Decai Wang, Ping Wei, Pingkai Ouyang	10
19	Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines 2010 ·European Journal of Medicinal Chemistry ·Huimin Cheng, Lianwen Zhang, Yingxue Liu, Shaopeng Chen, Hao Cheng, Xin Lü, (unknown), Guo‐Chun Zhou	57
20	Thiophene derivatives: a new series of potent norepinephrine and serotonin reuptake inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Ao Zhang, Guo‐Chun Zhou, (unknown), Kenneth M. Johnson, Mei Zhang, Alan P. Kozikowski	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact